Visioneering Technologies ( ASX:VTI ) Full Year 2023 Results Key Financial Results Revenue: US$8.67m (up 19% from FY...
NEW ORLEANS, October 12, 2023--VTI Unveils Interim 1-Year PROTECT RCT Data at AAOpt Annual Meeting; NaturalVue® Contact Lenses Proven Safe & Effective for Myopia Management
ATLANTA, August 30, 2023--US-based medical device firm, Visioneering Technologies, Inc (ASX:VTI), announced the hiring of Dr. Juan Carlos Aragón as Chief Executive Officer and Executive Director, starting October 1, 2023.